Halogen Dance on Thiazoles
HCl, water, and brine, dried over Na2SO4, and filtered and
the solvent evaporated. Purification by MPLC or recrystalli-
zation from DIPE gave the corresponding products.
N-(4,5-Dibromothiazol-2-yl)-2,2-dimethylpropana-
mide, 2: mp 112-114 °C; 93% (6.05 g, 17.69 mmol, brown
solid); MPLC DIPE; 1H NMR (CDCl3, 200 MHz) δ 1.31 (s, 9H),
9.03 (bs, 1H); 13C NMR (CDCl3, 50 MHz) δ 27.0 (q), 39.1 (s),
101.8 (s), 123.7 (s), 158.3 (s), 176.7 (s). Anal. Calcd for C8H10-
Br2N2OS‚0.15C6H14O (DIPE): C, 29.91; H, 3.41; N, 7.84.
Found: C, 29.96; H, 3.26; N, 7.88.
N-(4-Bromothiazol-2-yl)-2,2-dimethylpropanamide, 3:
pale yellow, slowly crystallizing (from DIPE) solid; mp 90-97
°C; 99% (0.50 g, 1.90 mmol); 1H NMR (CDCl3, 200 MHz) δ 1.32
(s, 9H), 6.85 (s, 1H), 8.93 (bs, 1H); 13C NMR (CDCl3, 50 MHz)
δ 27.1 (q), 39.1 (s), 111.3 (d), 120.8 (s), 158.7 (s), 176.4 (s). Anal.
Calcd for C8H11BrN2OS: C, 36.51; H, 4.21; N, 10.65. Found:
C, 36.74; H, 4.06; N, 10.54.
N-(4-Bromo-5-formylthiazol-2-yl)-2,2-dimethylpropan-
amide, 5a: mp 219-221 °C; 92% (1.02 g, 3.50 mmol, colorless
solid); MPLC PE/EtOAc 4:1; 1H NMR (CDCl3, 200 MHz) δ 1.34
(s, 9H), 9.13 (bs, 1H), 9.94 (s, 1H); 13C NMR (CDCl3, 50 MHz)
δ 27.0 (q), 39.5 (s), 126.6 (s), 133.0 (s), 163.7 (s), 176.8 (s), 183.3
(d). Anal. Calcd for C9H11BrN2O2S: C, 37.13; H, 3.81; N, 9.62.
Found: C, 36.97; H, 3.83; N, 9.34.
N-[4-Bromo-5-(1-hydroxycyclohex-1-yl)thiazol-2-yl]-
2,2-dimethylpropanamide, 5b: mp 147-149 °C; 73% (0.50
g, 1.39 mmol, colorless powder); MPLC PE/EtOAc 10:1; 1H
NMR (CDCl3, 200 MHz) δ 1.30 (s, 9H), 1.60-2.25 (m, 10H),
2.65 (bs, 1H), 8.88 (bs, 1H); 13C NMR (CDCl3, 50 MHz) δ 21.7
(t), 25.0 (t), 27.1 (q), 36.9 (t), 39.1 (s), 72.1 (s), 114.4 (s), 135.9
(s), 156.1 (s), 176.1 (s). Anal. Calcd for C14H21BrN2O2S: C,
46.54; H, 5.86; N, 7.75. Found: C, 46.66; H, 5.60; N, 7.56.
N-(4-Bromo-5-iodothiazol-2-yl)-2,2-dimethylpropana-
mide, 5c: mp 127-129 °C; 76% (5.61 g, 14.44 mmol, pale
yellow solid); MPLC PE/EtOAc 10:1; 1H NMR (CDCl3, 200
MHz) δ 1.31 (s, 9H), 8.97 (bs, 1H); 13C NMR (CDCl3, 50 MHz)
δ 27.0 (q), 39.0 (s), 66.9 (s), 130.1 (s), 162.5 (s), 176.6 (s). Anal.
Calcd for C8H10BrIN2OS: C, 24.70; H, 2.59; N, 7.20. Found:
C, 25.00; H, 2.67; N, 7.22.
N-[4-Bromo-5-(hydroxyphenylmethyl)thiazol-2-yl]-2,2-
dimethylpropanamide, 5d: mp 154-156 °C; 86% (0.60 g,
1.63 mmol, beige solid); MPLC PE/EtOAc 10:1; 1H NMR
(CDCl3, 200 MHz) δ 1.28 (s, 9H), 2.48 (bs, 1H), 6.09 (s, 1H),
7.28-7.42 (m, 3H), 7.45-7.53 (m, 2H), 8.81 (bs, 1H); 13C NMR
(CDCl3, 50 MHz) δ 27.0 (q), 39.1 (s), 70.5 (d), 118.8 (s), 125.9
(d), 128.2 (d), 128.7 (d), 131.2 (s), 141.7 (s), 158.3 (s), 176.4 (s).
Anal. Calcd for C15H17BrN2O2S: C, 48.79; H, 4.64; N, 7.59.
Found: C, 48.82; H, 4.54; N, 7.54.
N-(4-Bromo-5-trimethylsilylthiazol-2-yl)-2,2-dimethyl-
propanamide, 5e: mp 199-201 °C; 74% (0.189 g, 0.56 mmol,
colorless crystals); MPLC PE/EtOAc 10:1; 1H NMR (CDCl3, 200
MHz) δ 0.37 (s, 9H), 1.30 (s, 9H), 9.50 (bs, 1H); 13C NMR
(CDCl3, 50 MHz) δ -0.8 (q), 27.0 (q), 39.2 (s), 121.4 (s), 126.6
(s), 162.1 (s), 176.7 (s). Anal. Calcd for C11H19BrN2OSSi: C,
39.40; H, 5.71; N, 8.35. Found: C, 39.68; H, 5.66; N, 8.13.
N-(4-Bromo-5-trimethylsilylthiazol-2-yl)-N-phenylcar-
bamic acid 1,1-dimethylethyl ester, 15: mp 114-116 °C;
97% (0.35 g, 0.82 mmol, colorless crystals); MPLC PE/EtOAc
1
8:1; H NMR (CDCl3, 200 MHz) δ 0.38 (s, 9H), 1.42 (s, 9H),
7.16-7.25 (m, 2H), 7.31-7.49 (m, 3H); 13C NMR (CDCl3, 50
MHz) δ -0.7 (q), 28.0 (q), 83.7 (s), 121.7 (s), 127.2 (s), 128.1
(d), 128.3 (d), 129.1 (d), 139.0 (s), 152.8 (s), 165.2 (s). Anal.
Calcd for C17H23BrN2O2SSi: C, 47.77; H, 5.42; N, 6.55.
Found: C, 48.01; H, 5.31; N, 6.46.
N-(4-Bromo-5-trimethylsilylthiazol-2-yl)carbamic acid
1,1-dimethylethyl ester, 18: mp 143-145 °C; 76% (0.07 g,
1
0.20 mmol, pale yellow solid); MPLC PE/EtOAc 6:1; H NMR
(CDCl3, 200 MHz) δ 0.36 (s, 9H), 1.52 (s, 9H), 10.10 (bs, 1H);
13C NMR (CDCl3, 50 MHz) δ -0.8 (q), 28.1 (q), 82.8 (s), 119.9
(s), 126.5 (s), 152.5 (s), 164.4 (s).
N-[5-Bromo-3-methylthiazol-2(3H)-ylidene]-2,2-dimeth-
ylpropanamide, 6. Substance 1 (0.5 g, 1.90 mmol) was
dissolved in 5 mL of dry THF under argon atmosphere. A 1.2
equiv (20 mg) portion of LiH was added carefully and the
reaction mixture refluxed for 30 min. Subsequently, the
reaction was cooled to 0 °C, and 1.5 equiv of dimethyl sulfate
(0.36 g, 2.85 mmol) was added. The reaction mixture was
warmed to room temperature, diluted with EtOAc, washed
with 2 N HCl, water, and brine, dried over Na2SO4, and filtered
and the solvent evaporated. Recrystallization from DIPE gave
6: 98% (0.52 g, 1.88 mmol, colorless crystals); mp 165-166
°C; 1H NMR (CDCl3, 200 MHz) δ 1.26 (s, 9H), 3.68 (s, 3H),
6.92 (s, 1H); 13C NMR (CDCl3, 50 MHz) δ 27.8 (q), 35.5 (q),
40.5 (s), 98.1 (s), 126.2 (d), 167.3 (s), 188.6 (s). Anal. Calcd for
C9H13BrN2OS: C, 39.00; H, 4.73; N, 10.11. Found: C, 39.14;
H, 4.55; N, 10.09.
2,2-Dimethyl-N-phenyl-N-(thiazol-2-yl)propanamide,
8. Compound 7 (2.84 g, 16.1 mmol) was stirred in 50 mL of
dry THF, and NaH (0.46 g, 19.3 mmol) was added in small
portions over a period of 15 min. The reaction mixture was
stirred at rt for 1 h, and then pivaloyl chloride (2.33 g, 19.3
mmol) was added dropwise. After being refluxed overnight,
the reaction mixture was diluted with EtOAc (150 mL) and
poured onto water. The organic layer was washed with 2 N
HCl, water, and brine, dried over Na2SO4, filtered, and
concentrated. MPLC PE:EtOAc 6:1 gave 3.30 g (12.67 mmol,
79%) of 8 as a pale yellow solid: mp 116-117 °C; 1H NMR
(CDCl3, 200 MHz) δ 1.11 (s, 9H), 6.98 (d, 3.6 Hz, 1H), 7.31-
7.43 (m, 3H), 7.44-7.57 (m, 3H); 13C NMR (CDCl3, 50 MHz) δ
29.0 (q), 41.7 (s), 114.6 (d), 129.0 (d), 129.2 (d), 130.7 (d), 137.4
(d), 140.0 (s), 162.7 (s), 176.8 (s). Anal. Calcd for C14H16N2OS:
C, 64.59; H, 6.19; N, 10.76. Found: C, 64.68; H, 5.93; N, 10.83.
2,2-Dimethyl-(2-phenylaminothiazol-5-yl)propan-1-
one, 11. A solution of 8 in 1 mL of dry THF (0.2 g, 0.77 mmol,
1 equiv) was added dropwise at -80 °C to a solution of 1.1
equiv of LDA in 3 mL of dry THF. The reaction mixture was
slowly warmed to room temperature and then poured onto
water and extracted three times with EtOAc. The organic
layers were combined and washed with brine, dried over Na2-
SO4, and filtered, and the solvent was evaporated. Recrystal-
lization from DIPE gave 95% 11 (0.19 g, 0.73 mmol) as beige
1
N-[4-Bromo-5-(diphenylhydroxymethyl)thiazol-2-yl]-
2,2-dimethylpropanamide, 5f: mp 144-145 °C; 46% (0.23
g, 0.52 mmol, colorless solid); MPLC PE/EtOAc 10:1; 1H NMR
(CDCl3, 200 MHz) δ 1.26 (s, 9H), 3.93 (bs, 1H), 7.27-7.43 (m,
10H), 8.85 (bs, 1H); 13C NMR (CDCl3, 50 MHz) δ 27.0 (q), 39.0
(s), 78.2 (s), 119.1 (s), 127.3 (d), 128.1 (d), 128.2 (d), 134.0 (s),
144.6 (s), 156.9 (s), 176.3 (s).
N-(4-Bromo-5-trimethylsilylthiazol-2-yl)-2,2-dimethyl-
N-phenylpropanamide, 10: mp 138-139 °C; 69% (0.16 g,
0.57 mmol, colorless solid); recrystallized from DIPE; 1H NMR
(CDCl3, 200 MHz) δ 0.37 (s, 9H), 1.09 (s, 9H), 7.28-7.38 (m,
2H), 7.43-7.53 (m, 3H); 13C NMR (CDCl3, 50 MHz) δ -0.8 (q),
29.1 (q), 41.9 (s), 122.7 (s), 127.3 (s), 129.1 (d), 129.4 (d), 130.7
(d), 139.4 (s), 165.7 (s), 176.6 (s). Anal. Calcd for C17H23BrN2-
OSSi: C, 49.63; H, 5.63; N, 6.81. Found: C, 49.83; H, 5.47; N,
6.80.
solid: mp 148-150 °C; H NMR (CDCl3, 200 MHz) δ 1.36 (s,
9H), 7.11-7.23 (m, 1H), 7.30-7.50 (m, 4H), 7.99 (s, 1H), 9.46
(bs, 1H); 13C NMR (CDCl3, 50 MHz) δ 28.2 (q), 43.7 (s), 119.3
(d), 124.5 (d), 127.4 (s), 129.7 (d), 139.3 (s), 144.6 (d), 170.1
(s), 198.1 (s).
BOC Protection of 2-Thiazolamines 7 and 16. The
corresponding 2-thiazolamine (7 or 16, 1 equiv) was refluxed
in dry THF in the presence of a catalytic amount of DMAP.
Then pyrocarbonic acid di-tert-butyl ester (1.5 equiv for
preparation of 12, 2.4 equiv for preparation of 17) was
dissolved in dry THF, added dropwise to the reaction mixture,
and refluxed overnight. The reaction solution was poured onto
ice-water and neutralized with a few drops of 2 N HCl. The
resulting solution was extracted three times with Et2O, and
the combined organic layers were washed with water and
brine, dried over Na2SO4, filtered, and concentrated. If neces-
J. Org. Chem, Vol. 70, No. 2, 2005 573